The Riegelmann Boardwalk in Coney Island will get a $1 billion makeover. As part of the full reconstruction of the nearly ...
CTA311 is an investigational ‘ready-at-point of care’ allogeneic anti-CD19 CAR-T cell therapy designed for B-cell mediated disease. The product candidate incorporates T-cell receptor (TCR) and HLA ...